Skip to main content

HPV Awareness Day

Human Papilloma Virus (HPV) is a major leading cause of Human Cancer. Through this series we would like to highlight the quality and the breadth of the research being carried out on the Control and Prevention of HPV and HPV related disease. This series aims to bring together a diverse range of HPV related specialities featuring research that has as ultimate goal insights into HPV related disease reduction. Articles can have a wide range of topics such as those of natural history studies, impact of screening interventions or impact of HPV vaccines will be most welcome.

Relevant research papers published in Infectious Agents and Cancer will be added to the series, with commentary to explain their significance, or put them in context for no specialist readers.

The section includes:

  • News on HPV research, highlight of events or articles that deserve particular attention for their relevance or controversy
  • A major research article on HPV with priority for community trials or demonstration projects of preventive strategies
  • A collection of relevant articles that relate to HPV disease reduction.

This collection of articles is a retrospective collection, has not been sponsored and the articles have undergone the journal's standard peer-review process.

Edited by:
Franco M Buonaguro, MD, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" , Italy
Maria Lina Tornesello, MD, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" , Italy

View all collections published in Infectious Agents and Cancer.

  1. WHO has recommended HPV testing for cervical screening where it is practical and affordable. If used, it is important to both clarify and implement the clinical management of positive results. We estimated the...

    Authors: Groesbeck P. Parham, Didem Egemen, Brian Befano, Mulindi H. Mwanahamuntu, Ana Cecilia Rodriguez, Sameer Antani, Samson Chisele, Mukatimui Kalima Munalula, Friday Kaunga, Francis Musonda, Evans Malyangu, Aaron Lunda Shibemba, Silvia de Sanjose, Mark Schiffman and Vikrant V. Sahasrabuddhe
    Citation: Infectious Agents and Cancer 2023 18:61
  2. Despite the global vaccination campaign to prevent HPV-related morbidity, HPV vaccination uptake remains unacceptably low in the developing world, like Ethiopia. For strong interventional measures, compiled da...

    Authors: Awoke Derbie, Daniel Mekonnen, Eyaya Misgan, Melanie Maier, Yimtubezinash Woldeamanuel and Tamrat Abebe
    Citation: Infectious Agents and Cancer 2023 18:59
  3. This report covers the case of 7 women affected by pathologies related to genital Herpesvirus and Papillomavirus. They were referred to the gynaecology outpatient clinic for colposcopic examination, and receiv...

    Authors: Maria Balestrieri, Caterina Carnovale-Scalzo, Anna Rosa Garbuglia, Maria Vincenza Chiantore, Luisa Accardi and Paola Di Bonito
    Citation: Infectious Agents and Cancer 2023 18:36
  4. For women living with HIV (WLHIV), the burden of persistent HPV infection, cervical pre-cancerous lesions and cancer have been demonstrated to be higher than among HIV-negative women. As Ghana and other lower-...

    Authors: Patrick Kafui Akakpo, Sebastian Ken-Amoah, Nancy Innocentia Ebu Enyan, Elizabeth Agyare, Emmanuel Salia, Ibrahim Baidoo, Leonard Derkyi-Kwarteng, Matthew Asare, George Adjei, Stephen Ayisi Addo and Dorcas Obiri-Yeboah
    Citation: Infectious Agents and Cancer 2023 18:33
  5. Head and neck squamous cell carcinoma (HNSCC) is a heterogeneous tumor with diverse molecular pathological profiles. Recent studies have suggested the vital role of pyroptosis in tumor microenvironment. Howeve...

    Authors: Doudou Li, Dong Ma and Yuxia Hou
    Citation: Infectious Agents and Cancer 2023 18:30
  6. Low- and middle-income countries (LMICs) account for nearly 85% of the global cervical cancer burden, yet have the least access to high-performance screening. International guidelines recommend human papilloma...

    Authors: Sikhulile Moyo, Doreen Ramogola-Masire, Natasha O. Moraka, Leabaneng Tawe, Farzad Noubary, Kesego Motsumi, Godiraone Manowe, Boitumelo Zuze, Botshelo Radibe, Faith T. T. Hungwe, Terence Mohammed, Comfort Maphorisa, Roger Shapiro, Simani Gaseitsiwe and Rebecca Luckett
    Citation: Infectious Agents and Cancer 2023 18:29
  7. HPV-31, -33, and -58, along with HPV-45 and -52, account for almost 11% of HPV-associated cancers. Our previous studies showed that after HPV-16 and -51, HPV-58 was common and HPV-31 was as frequent as HPV-18 ...

    Authors: Mina Mobini Kesheh, Sara Shavandi, Jalil Azami, Maryam Esghaei and Hossein Keyvani
    Citation: Infectious Agents and Cancer 2023 18:19
  8. Cervical cancer is the third most common cancer among women worldwide, but particularly affects women living in sub-Saharan Africa. Screening and vaccination programs are two prevention approaches that can red...

    Authors: Pamela Moussavou-Boundzanga, Ismaël Hervé Koumakpayi, Corinne Engohan Aloghe, Junie K. Chansi, Rose Revignet, Eric M. Leroy and Nicolas Berthet
    Citation: Infectious Agents and Cancer 2023 18:16
  9. Among human tumorigenic viruses, the role of Human papillomavirus (HPV) has been proven as one of the most important oncoviruses that are associated with a large number of cancers. Most cancers of the genital ...

    Authors: Vahideh Hamidi Sofiani, Parsa Veisi, Mohammad Rezaei Zadeh Rukerd, Reza Ghazi and Mohsen Nakhaie
    Citation: Infectious Agents and Cancer 2023 18:13
  10. Human papillomavirus (HPV) genotypes differ by geographic location. With the advent of HPV vaccination and HPV-based cervical screening tests in Ethiopia, a nationwide dataset on the genotype distribution of H...

    Authors: Awoke Derbie, Melanie Maier, Bereket Amare, Eyaya Misgan, Endalkachew Nibret, Uwe G. Liebert, Yimtubezinash Woldeamanuel and Tamrat Abebe
    Citation: Infectious Agents and Cancer 2023 18:4